Clin2
NCT06219135Likely a fitRecruiting

Testing a new method to find infection germs and best antibiotics

Sepsis

Part of Infections clinical trials.

This trial is testing a new method (IDBIORIV) to quickly identify the germs causing sepsis and find the right antibiotic. It aims to help patients with a confirmed bloodstream infection get the most effective treatment faster.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,372 people
Ages
1 day and older
Study type
Observational

Who can take part

  • You are an adult or child currently in the hospital.
  • You have signs of an infection (like fever or fast breathing).
  • A blood test has confirmed that you have germs (such as bacteria) in your blood (called a positive blood culture).
  • You or a family member has agreed to take part in this study.
  • You are not under a court-ordered protection, like guardianship or curatorship.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06531031Not yet recruiting
Blood infection test study for patients in the hospital

This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.

Indianapolis, Indiana
NCT06103500Recruiting
Helping choose the right antibiotic for sepsis

This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.

Mississauga, Ontario
NCT06018792Recruiting
New blood test for faster sepsis diagnosis in children

This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.

Amsterdam
NCT06178822Recruiting
New blood tests to diagnose sepsis in the ER

This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.

Almere Stad, Flevoland
NCT06745115Recruiting
Using blood fluorescence to detect sepsis

This trial tests a new way to detect sepsis using fluorescence from a blood sample. It may help doctors identify sepsis earlier and improve treatment.

Guangzhou, Guangdong
NCT06657625Enrolling by invitation
Improving sepsis care in the emergency department

This trial looks at a new program to improve how doctors and nurses treat sepsis (a severe infection that can cause organ failure) in the emergency department. It aims to see if the program helps start the right treatments faster.

Brest

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.